Records 1 - 6
| Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer.
FEBS open bio 2022 Oct .
Xu Fei, Cui Wen-Qiang, Liu Cun, Feng Fubin, Liu Ruijuan, Zhang Jingtao, Sun Chang-Ga
| Genomic features of Chinese small cell lung cancer.
BMC medical genomics 2022 May 15 (1): 117.
Liu Jun, Zhao Zhuxiang, Wei Shuquan, Li Binkai, Zhao Ziw
| Molecular and Clinicopathological Characteristics of Lung Cancer Concomitant Chronic Obstructive Pulmonary Disease (COPD).
International journal of chronic obstructive pulmonary disease 2022 17 1601-1612.
Ma Hongxia, Zhang Qian, Zhao Yanwen, Zhang Yaohui, Zhang Jingjing, Chen Guoqing, Tan Yuan, Zhang Qin, Duan Qianqian, Sun Tingting, Qi Chuang, Li Fengs
| Co-Mutation of FAT3 and LRP1B in Lung Adenocarcinoma Defines a Unique Subset Correlated With the Efficacy of Immunotherapy.
Frontiers in immunology 2021 12 800951.
Zhu Mingyu, Zhang Lu, Cui Haiyan, Zhao Qiang, Wang Hao, Zhai Baochao, Jiang Richeng, Jiang Zhanshe
| Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib.
Scientific reports 2020 Nov 10 (1): 20243.
Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L
| Integrative analysis of genomic sequencing data reveals higher prevalence of LRP1B mutations in lung adenocarcinoma patients with COPD.
Scientific reports 2017 05 7 (1): 2121.
Xiao Dakai, Li Fuqiang, Pan Hui, Liang Han, Wu Kui, He Jianxi